Upper Tract Tumors - Results from #1080

Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a - Abstract November 29, 2011

Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma - Abstract November 11, 2011

High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy - Abstract November 9, 2011

Urothelial carcinoma of the bladder: Definition, treatment and future efforts - Abstract November 2, 2011

hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas - Abstract November 2, 2011

Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: A randomized phase 2 study of the French Genitourinary Tumor Group (GET November 2, 2011

Tissue engineering potential of urothelial cells from diseased bladders - Abstract October 17, 2011

Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma - Abstract October 12, 2011

Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis - Abstract October 10, 2011

Upper urinary tract transitional cell carcinoma: Location is not correlated with prognosis - Abstract October 3, 2011

DGU 2011 - Prospective, randomized, double-blind, multicenter phase-II trial comparing gemcitabine/cisplatinum +/- sorafenib in locally advanced or metastatic urothelial cancer of the bladder (AUO-trial AB 31/05) - Session Highlights September 28, 2011

DGU 2011 - Impact of kidney function on the accuracy of urine-based tests for the diagnosis of urothelial cancer of the bladder - Session Highlights September 27, 2011

DGU 2011 - Prospective long-term trial “UroScreen” for the early diagnosis of urothelial cancer of the bladder in a risk cohort of patient using urine-based tests - Session Highlights September 27, 2011

Expression of the tumormarker p16INK4a in cytology specimens of the urinary bladder : A new means for early recognition and surveillance of urothelial cancer - Abstract September 19, 2011

External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder - Abstract September 15, 2011

Prognostic factors in second-line treatment of urothelial cancers with gemcitabine and paclitaxel (German Association of Urological Oncology Trial AB20/99) - Abstract September 14, 2011

Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC) - Abstract September 12, 2011

High-grade papillary urothelial carcinoma of the urinary tract: A clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center - Abstract September 6, 2011

The diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: A systematic review and meta-analysis - Abstract September 5, 2011

Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status - Abstract August 30, 2011

Page 55 of 58